NCT05538585View on ClinicalTrials.gov

A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 27, 2022

Primary Completion Date

December 21, 2022

Study Completion Date

December 21, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

Galicaftor

Oral

DRUG

Navocaftor

Oral

Trial Locations (2)

33014

Clinical Pharmacology of Miami /ID# 249531, Miami

60030

Acpru /Id# 249532, Grayslake

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY